Shandong Weigao Group Medical Polymer Co (Shandong Weigao Group Medical Polymer Co) Risk Assessment

View and export this data going back to 2011. Start your Free Trial

What is Shandong Weigao Group Medical Polymer Co Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Shandong Weigao Group Medical Polymer Co is: High Risk: Good fundamentals, beware of shrinking business.

Competitive Comparison of Shandong Weigao Group Medical Polymer Co's Risk Assessment

For the Medical Instruments & Supplies subindustry, Shandong Weigao Group Medical Polymer Co's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shandong Weigao Group Medical Polymer Co's Risk Assessment Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shandong Weigao Group Medical Polymer Co's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Shandong Weigao Group Medical Polymer Co's Risk Assessment falls into.

Shandong Weigao Group Medical Polymer Co (OTCPK:SHWGY) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Shandong Weigao Group Medical Polymer Co Risk Assessment Related Terms

Thank you for viewing the detailed overview of Shandong Weigao Group Medical Polymer Co's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Weigao Group Medical Polymer Co (Shandong Weigao Group Medical Polymer Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shandong Weigao Group Medical Polymer Co Ltd (OTCPK:SHWGY) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

SHWGF:USA 01066:Hong Kong UK2:Germany

Address

No.1, Weigao Road, Torch Hi-tech Science Park, Shandong Province, Weihai, CHN

Website

https://www.weigaogroup.com

Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.

Shandong Weigao Group Medical Polymer Co (Shandong Weigao Group Medical Polymer Co) Headlines

From GuruFocus

Shandong Weigao Group Medical Polymer Co Ltd's Dividend Analysis

By GuruFocus Research • 10-26-2023

ACell Enters Exclusive Chinese Product Supply and Distribution Agreement for Cytal and MicroMatrix Wound Management Products

By PRNewswire PRNewswire • 04-08-2019